Form 8-K - Current report:
SEC Accession No. 0001628280-21-019542
Filing Date
2021-10-04
Accepted
2021-10-04 16:17:49
Documents
12
Period of Report
2021-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K ocgn-20210929.htm   iXBRL 8-K 39697
  Complete submission text file 0001628280-21-019542.txt   175057

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocgn-20210929.xsd EX-101.SCH 1896
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocgn-20210929_lab.xml EX-101.LAB 23832
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocgn-20210929_pre.xml EX-101.PRE 12504
5 EXTRACTED XBRL INSTANCE DOCUMENT ocgn-20210929_htm.xml XML 10627
Mailing Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 211302966
SIC: 2836 Biological Products, (No Diagnostic Substances)